Bids Are Invited For Central Purchase - Medicines Ii in Brazil

Work Detail

Abemaciclib Active Ingredient: Abemaciclib; Concentration/Dosage: 100 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Component: .;, Abemaciclib Active Ingredient: Abemaciclib; Concentration/Dosage: 200 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Component: .;, Acalabrutinib - Active Ingredient: Acalabrutinib; Concentration/Dosage: 100 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Component: Polyacrylic Acid - Active Ingredient: Polyacrylic Acid; Concentration/Dosage: 2 Mg/G; Pharmaceutical Form: Ophthalmic Gel; Presentation: Packaging 10, Afatinib - Active Ingredient: Afatinib, Dimaleate; Concentration/Dosage: 30 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Component: Afatinib - Active Ingredient: Afatinib; Concentration/Dosage: 40 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Component: .;, Alprostadil - Active Ingredient: Alprostadil; Concentration/Dosage: 20 Mcg; Pharmaceutical Form: Lyophilized Powder For Injectable Solution; Presentation: Fra, Alprostadil - Active Ingredient: Alprostadil; Concentration/Dosage: 500 Mcg/Ml; Pharmaceutical Form: Injectable Solution; Presentation: 1 Ml Ampoule; Compon, Alteplase - Active Ingredient: Alteplase; Concentration/Dosage: 10 Mg; Pharmaceutical Form: Lyophilized Powder For Injectable Solution; Presentation: Vial-A, Alteplase - Active Ingredient: Alteplase; Concentration/Dosage: 50 Mg; Pharmaceutical Form: Lyophilized Powder For Injectable Solution; Presentation: Vial-A, Amphotericin B - Active Ingredient: Amphotericin B In Sodium Deoxycholate; Concentration/Dosage: 50 Mg; Pharmaceutical Form: Freeze-Dried Powder; Presentation, Apalutamide - Active Ingredient: Apalutamide; Concentration/Dosage: 60 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Component: .;, Argipressin - Active Ingredient: Argipressin; Concentration/Dosage: 20 U/Ml; Pharmaceutical Form: Injectable Solution; Presentation: 1 Ml Ampoule; Compone, Atezolizumab Active Ingredient: Atezolizumab; Concentration/Dosage: 1,200 Mg; Pharmaceutical Form: Concentrate For Infusion Solution; Presentation, Atropine - Active Ingredient: Atropine, Sulfate; Concentration/Dosage: 0.5 Mg/Ml; Pharmaceutical Form: Injectable Solution; Presentation: 1 Ml Ampoule; Comp, Sulfate; Concentration/Dosage: 10 Mg/Ml (1%); Pharmaceutical Form: Ophthalmic Solution; Presentation: 5 Ml Bottle, Sulfate; Concentration/Dosage: 5 Mg/Ml; Pharmaceutical Form: Ophthalmic Solution; Presentation: 5 Ml Bottle; Compon, Baricitinib - Active Ingredient: Baricitinib; Concentration/Dosage: 4 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Component: .;, Beclomethasone + Associations - Active Ingredient (1): Beclomethasone, Dipropionate; Active Ingredient (2): Formoterol Fumarate Dihydrate+Glycopyrroni Bromide, Dipropionate; Active Ingredient (2): Formoterol, Fumarate; Concentration/Dosage: 100 M, Belimumab - Active Ingredient: Belimumab; Concentration/Dosage: 120 Mg; Pharmaceutical Form: Lyophilized Powder For Injectable Solution; Presentation: Frasc, Belimumab - Active Ingredient: Belimumab; Concentration/Dosage: 400 Mg; Pharmaceutical Form: Lyophilized Powder For Injectable Solution; Presentation: Frasc, Procaine Benzylpenicillin + Associations - Active Ingredient (1): Procaine Benzylpenicillin; Active Ingredient (2): Benzylpenicillin Potassium; Concentraca, Binimetinib - Active Ingredient: Binimetinib; Concentration/Dosage: 15 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Component: .;, Ipratro Bromide

Contact Information